Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer

Linderholm, Barbro K. ; Gruvberger, Sofia LU ; Fernö, Mårten LU ; Bendahl, Pär-Ola LU and Malmström, Per LU (2008) In Breast 17(5). p.484-491
Abstract
We investigate the prognostic significance of the pro-angiogenic cytokine vascular endothelial growth factor (VEGF), urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor 1 (PAI-1), and S-phase fraction (SPF) for distant disease free survival (DDFS) in 219 premenopausal patients with node-negative breast cancer (NNBC). In univariate analysis significantly shorter DDFS was observed for patients with high VEGF (p = 0.006), high uPA (p = 0.001). and high SPF (p < 0.001). The prognostic significance of VEGF varied over time being very, strong for early relapses (0-2.25 years follow-up) (HR = 7.9: p = 0.006) while no difference was seen in the subsequent follow-up period (HR = 1.3: p = 0.62). In a series of bivariate... (More)
We investigate the prognostic significance of the pro-angiogenic cytokine vascular endothelial growth factor (VEGF), urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor 1 (PAI-1), and S-phase fraction (SPF) for distant disease free survival (DDFS) in 219 premenopausal patients with node-negative breast cancer (NNBC). In univariate analysis significantly shorter DDFS was observed for patients with high VEGF (p = 0.006), high uPA (p = 0.001). and high SPF (p < 0.001). The prognostic significance of VEGF varied over time being very, strong for early relapses (0-2.25 years follow-up) (HR = 7.9: p = 0.006) while no difference was seen in the subsequent follow-up period (HR = 1.3: p = 0.62). In a series of bivariate analyses VEGF provided prognostic information during the whole observation period (0-72 months) in addition to age, tumor size, oestrogen receptor (ER), progesterone receptor (PgR), and uPA. Also this effect was more pronounced during the first follow-up period suggesting VEGF as a marker of early recurrences. (C) 2008 Elsevier Ltd. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Early relapses, S-phase fraction (SPF), activator (uPA), Vascular endothelial growth factor (VEGF), Urokinase-type plasminogen, Premenopausal, lymph node-negative breast cancer
in
Breast
volume
17
issue
5
pages
484 - 491
publisher
Churchill Livingstone
external identifiers
  • wos:000260896700009
  • scopus:53149153529
  • pmid:18508268
ISSN
1532-3080
DOI
10.1016/j.breast.2008.02.010
language
English
LU publication?
yes
id
09e3c7cc-73e5-4695-842a-47074423b811 (old id 1283652)
date added to LUP
2016-04-01 13:34:31
date last changed
2022-01-27 19:53:06
@article{09e3c7cc-73e5-4695-842a-47074423b811,
  abstract     = {{We investigate the prognostic significance of the pro-angiogenic cytokine vascular endothelial growth factor (VEGF), urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor 1 (PAI-1), and S-phase fraction (SPF) for distant disease free survival (DDFS) in 219 premenopausal patients with node-negative breast cancer (NNBC). In univariate analysis significantly shorter DDFS was observed for patients with high VEGF (p = 0.006), high uPA (p = 0.001). and high SPF (p &lt; 0.001). The prognostic significance of VEGF varied over time being very, strong for early relapses (0-2.25 years follow-up) (HR = 7.9: p = 0.006) while no difference was seen in the subsequent follow-up period (HR = 1.3: p = 0.62). In a series of bivariate analyses VEGF provided prognostic information during the whole observation period (0-72 months) in addition to age, tumor size, oestrogen receptor (ER), progesterone receptor (PgR), and uPA. Also this effect was more pronounced during the first follow-up period suggesting VEGF as a marker of early recurrences. (C) 2008 Elsevier Ltd. All rights reserved.}},
  author       = {{Linderholm, Barbro K. and Gruvberger, Sofia and Fernö, Mårten and Bendahl, Pär-Ola and Malmström, Per}},
  issn         = {{1532-3080}},
  keywords     = {{Early relapses; S-phase fraction (SPF); activator (uPA); Vascular endothelial growth factor (VEGF); Urokinase-type plasminogen; Premenopausal; lymph node-negative breast cancer}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{484--491}},
  publisher    = {{Churchill Livingstone}},
  series       = {{Breast}},
  title        = {{Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer}},
  url          = {{http://dx.doi.org/10.1016/j.breast.2008.02.010}},
  doi          = {{10.1016/j.breast.2008.02.010}},
  volume       = {{17}},
  year         = {{2008}},
}